找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Managing Cancer during Pregnancy; Hatem A. Azim Jr Book 2016 Springer International Publishing Switzerland 2016 Cancer in Pregnancy.Chemot

[復制鏈接]
樓主: Clinton
41#
發(fā)表于 2025-3-28 14:37:26 | 只看該作者
Contributions and Risks of Radiation Therapy in Managing Cancer During Pregnancyy shielding can further decrease the foetal dose. Also, in case of multimodality treatment, adaptation of the order of treatment modalities could be considered. Benefits and disadvantages should then be weighed against each other together with the future parents. This chapter gives an overview of th
42#
發(fā)表于 2025-3-28 19:24:54 | 只看該作者
Pharmacokinetics of Systemic Anticancer Therapies During Pregnancyn drug safety in one hand and in drug efficacy in the other hand. We will focus in this chapter on the pharmacokinetic changes occurring during pregnancy leading to potential changes in drug dosing and subsequently in their transplacental transfer. Recent preclinical and clinical available data rega
43#
發(fā)表于 2025-3-28 23:43:43 | 只看該作者
44#
發(fā)表于 2025-3-29 05:51:10 | 只看該作者
Neonatal and Long-Term Consequences of In Utero Exposure to Systemic Anticancer Therapynduce hearing loss, especially when high dosages are used. Since prematurity has been related to decreased cognitive functioning, postponement of delivery can be achieved by maternal cancer treatment during pregnancy. Overall, the use of several chemotherapeutic agents during pregnancy is considered
45#
發(fā)表于 2025-3-29 08:45:09 | 只看該作者
46#
發(fā)表于 2025-3-29 13:17:12 | 只看該作者
Managing Ovarian Tumors During Pregnancyhould be properly informed about the risks and benefits of any procedure. It is recommended that patients are referred to specialized centers that may guarantee the best outcome..Systemic chemotherapy may be safely administered after the second trimester: its use should be carefully evaluated consid
47#
發(fā)表于 2025-3-29 19:27:23 | 只看該作者
48#
發(fā)表于 2025-3-29 20:51:59 | 只看該作者
49#
發(fā)表于 2025-3-30 03:09:59 | 只看該作者
50#
發(fā)表于 2025-3-30 04:36:34 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 23:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
乌拉特前旗| 神木县| 扶余县| 察隅县| 松溪县| 仁化县| 天津市| 江安县| 凭祥市| 乐至县| 花莲市| 行唐县| 阜康市| 贵州省| 常德市| 乐业县| 禹城市| 宝清县| 贡嘎县| 林甸县| 巴东县| 诸城市| 长治市| 邵阳市| 察雅县| 昌黎县| 临朐县| 洪雅县| 曲阳县| 湛江市| 沐川县| 修文县| 昌都县| 刚察县| 平湖市| 景德镇市| 屏山县| 通许县| 盱眙县| 金坛市| 塔河县|